CDK2 and cancer: discovered that NPTX1 suppressed cancer cell proliferation by regulating the retinoblastoma protein-E2F transcription factor signaling pathway via repression of cyclin A2 and cyclin-dependent kinases 2 (CDK2) expression (42).